These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Clopidogrel-induced hepatotoxicity after percutaneous coronary stenting.
    Author: Chau TN, Yim KF, Mok NS, Chan WK, Leung VK, Leung MF, Lai ST.
    Journal: Hong Kong Med J; 2005 Oct; 11(5):414-6. PubMed ID: 16219965.
    Abstract:
    Clopidogrel, an adenosine diphosphate receptor blocker, is widely used as an adjunctive antiplatelet therapy in acute coronary syndrome and percutaneous coronary stenting. The occurrence of hepatotoxicity is rare. We describe the occurrence of symptomatic liver disease in a 74-year-old man 5 weeks following commencement of therapy with clopidogrel. The reported cases of clopidogrel-induced hepatotoxicity are reviewed and the clinical significance of this event are discussed.
    [Abstract] [Full Text] [Related] [New Search]